Related Experiment Videos
Which markers of inflammation should be used in therapeutic intervention studies of CB/COAD?
P Venge1, R Brattsand, L A Laitinen
1Department of Clinical Chemistry, University Hospital, Uppsala, Sweden.
Agents and Actions. Supplements
|January 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Nasal secretions and exudations : collection and approaches to analysis.
Methods in molecular medicine·2011
Smoking strongly predicts disability retirement due to COPD: the Finnish Twin Cohort Study.
The European respiratory journal·2010
Predictors of COPD symptoms: does the sex of the patient matter?
The European respiratory journal·2006
Ro 45-2081, a TNF receptor fusion protein, prevents inflammatory responses in the airways.
Agents and actions. Supplements·1998
Immunomodulation of Crohn's disease by interleukin-10.
Agents and actions. Supplements·1998
Cartilage protective agent (CPA) Ro 32-3555, a new matrix metalloproteinase inhibitor for the treatment of rheumatoid arthritis.
Agents and actions. Supplements·1998
The complexity of the B7-CD28/CTLA-4 costimulatory pathway.
Agents and actions. Supplements·1998
A role for inflammatory cytokines in the productive activation of antigen-specific CD4+ T-cells.
Agents and actions. Supplements·1998
CD40 and its ligand in cell-mediated immunity.
Agents and actions. Supplements·1998
Occult Penetrating Trauma: A STEMI Mimic Hiding in Plain Sight.
JACC. Case reports·2026
Occupational Disparities in Cardiovascular Risk and Management in Contemporary China.
Journal of the American College of Cardiology·2026